"Naproxen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.
| Descriptor ID |
D009288
|
| MeSH Number(s) |
D02.455.426.559.847.638.472.500 D04.615.638.472.450
|
| Concept/Terms |
Naproxen Sodium- Naproxen Sodium
- Sodium, Naproxen
- Sodium Naproxenate
- Naproxenate, Sodium
|
Below are MeSH descriptors whose meaning is more general than "Naproxen".
Below are MeSH descriptors whose meaning is more specific than "Naproxen".
This graph shows the total number of publications written about "Naproxen" by people in this website by year, and whether "Naproxen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2018 | 2 | 1 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Naproxen" by people in Profiles.
-
Ultrasound and magnetic resonance imaging-based investigation of the role of perfusion and oxygen availability in menstrual pain. Am J Obstet Gynecol. 2024 05; 230(5):553.e1-553.e14.
-
Validating a biosignature-predicting placebo pill response in chronic pain in the settings of a randomized controlled trial. Pain. 2022 05 01; 163(5):910-922.
-
Development and validation of a real-time method characterizing spontaneous pain in women with dysmenorrhea. J Obstet Gynaecol Res. 2021 Apr; 47(4):1472-1480.
-
Low Serum Naproxen Concentrations Are Associated with Minimal Pain Relief: A Preliminary Study in Women with Dysmenorrhea. Pain Med. 2020 11 01; 21(11):3102-3108.
-
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study. Arthritis Rheumatol. 2019 01; 71(1):143-153.
-
Preparation, Characterization, and Formulation Development of Drug-Drug Protic Ionic Liquids of Diphenhydramine with Ibuprofen and Naproxen. Mol Pharm. 2018 09 04; 15(9):4190-4201.
-
Abdominal skeletal muscle activity precedes spontaneous menstrual cramping pain in primary dysmenorrhea. Am J Obstet Gynecol. 2018 07; 219(1):91.e1-91.e7.
-
Cardiorenal Safety of OTC Analgesics. J Cardiovasc Pharmacol Ther. 2018 03; 23(2):103-118.
-
Effects of naproxcinod on blood pressure in patients with osteoarthritis. Am J Cardiol. 2011 May 01; 107(9):1338-45.
-
Intra-renal oxygenation in rat kidneys during water loading: effects of cyclooxygenase (COX) inhibition and nitric oxide (NO) donation. J Magn Reson Imaging. 2010 Aug; 32(2):383-7.